<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://3sixtypharma.com/wp-sitemap.xsl" ?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://3sixtypharma.com/2015/01/04/medical-education/</loc><lastmod>2016-05-11T15:11:04-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2015/01/04/marketing/</loc><lastmod>2016-05-11T15:10:37-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2015/01/04/clinical-research-operations/</loc><lastmod>2016-05-11T15:10:10-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2015/01/04/medical-science-liaison-academy/</loc><lastmod>2016-05-11T15:09:27-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/05/11/372/</loc><lastmod>2016-05-20T12:15:36-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/05/16/fascinating-science-synthetic-human-genome/</loc><lastmod>2016-05-20T16:06:35-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/05/17/new-phrma-commissioned-report/</loc><lastmod>2016-05-20T12:13:10-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/05/18/update-human-genome-synthesis/</loc><lastmod>2016-05-18T12:06:04-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/05/18/melanoma-drug-verge-breakthrough/</loc><lastmod>2016-05-20T12:13:47-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/05/20/pharmacogenomics-answer-personal-problem/</loc><lastmod>2016-05-20T12:24:58-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/05/20/new-data-chemotherapy-resistance-ovarian-cancer/</loc><lastmod>2016-05-20T15:16:54-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/05/21/patients-in-clinical-trials-insights/</loc><lastmod>2016-05-22T11:59:00-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/05/22/governance-essential-portfolioprogramproject-management-difficult-define/</loc><lastmod>2016-05-22T12:07:34-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/05/22/project-management-salaries/</loc><lastmod>2016-05-23T14:39:19-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/05/23/insights-passive-candidates-fill-hr-pipelines/</loc><lastmod>2016-05-23T15:44:33-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/05/25/cutting-edge-oncology-research-progresses-quickly-anticipated/</loc><lastmod>2016-05-25T09:12:10-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/05/25/medication-reminder-app/</loc><lastmod>2016-05-25T18:01:25-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/06/02/dementia-yes-not-alzheimers/</loc><lastmod>2016-06-02T16:28:23-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/05/26/pipeline-biosimilar-asthma/</loc><lastmod>2016-05-26T08:53:53-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/06/01/mit-novartis-prototype/</loc><lastmod>2016-06-01T12:53:31-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/06/02/genetically-modified-t-cell-therapy/</loc><lastmod>2016-06-02T12:44:29-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/05/31/secret-sauce-productive-meetings/</loc><lastmod>2016-06-14T09:28:53-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/06/02/risk-management-companies-waste-122-million-for-every-1b-need-greater-investment-in-pm/</loc><lastmod>2018-01-13T15:02:48-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/06/02/deadline-july-2-fdas-omb/</loc><lastmod>2018-01-13T15:01:15-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/06/11/pharma-spending-pd-1/</loc><lastmod>2016-10-08T12:11:29-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/06/10/gi-oral-jak-inhibitor-td-1473/</loc><lastmod>2016-06-11T16:40:06-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/06/10/biosimilar-switching/</loc><lastmod>2016-06-11T16:44:06-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/10/08/special-event-bio-threat-awareness/</loc><lastmod>2018-01-13T14:38:18-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2016/10/08/communication-key-piece-empowering-teams/</loc><lastmod>2018-01-13T14:35:25-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2017/02/21/biopharmaceutical-consulting-in-2016-and-beyond-a-njbpng-event/</loc><lastmod>2018-01-13T14:35:34-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2017/05/11/3sixty-pharma-solutions-profiled-in-montgomery-county-newspaper/</loc><lastmod>2018-01-13T14:19:17-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2017/05/18/were-so-excited-to-meet-you-next-week-at-magi-2017-east/</loc><lastmod>2018-01-13T14:17:57-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2017/05/27/thank-you-for-visiting-the-3sixty-pharma-booth-at-magi/</loc><lastmod>2018-01-13T14:16:56-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2017/06/24/fda-issues-qa-draft-guidance-use-of-electronic-records-and-electronic-signatures-in-clinical-investigations/</loc><lastmod>2018-01-13T14:14:35-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2017/06/27/fda-aims-to-increase-rx-drug-competition-facilitate-generics/</loc><lastmod>2018-01-13T14:14:05-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2017/11/19/fda-orphan-drug-strategy/</loc><lastmod>2018-01-13T14:18:28-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2017/11/19/fda-on-postmarket-drug-safety/</loc><lastmod>2018-01-13T14:10:45-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2018/01/11/strategies-tactics-for-clinical-research-project-management/</loc><lastmod>2018-01-13T14:08:10-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2018/01/13/3sixty-pharma-solutions-earns-fourth-certification/</loc><lastmod>2018-01-13T14:57:17-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2018/05/06/working-across-cultures-minimizing-the-impact-while-conducting-clinical-trials/</loc><lastmod>2018-05-06T15:15:41-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2018/06/04/bio-2018-in-boston/</loc><lastmod>2018-06-04T20:52:00-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2018/06/09/great-conversations-at-bio/</loc><lastmod>2018-06-09T19:02:36-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2018/07/22/proud-to-support-cutting-edge-rare-disease-symposium/</loc><lastmod>2018-07-22T15:42:28-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2018/09/13/risk-management-in-device-trials/</loc><lastmod>2018-09-13T11:47:45-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2018/11/27/3sixty-pharma-solutions-dartmouth-tuck/</loc><lastmod>2018-11-28T15:24:38-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2019/03/11/join-us-at-acrp-in-nashville-april-12-15/</loc><lastmod>2019-03-11T11:32:51-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2019/03/27/innovation-in-research-2019-proud-supporters-of-westchester-biotech-projects-march-27-program/</loc><lastmod>2019-03-27T13:10:11-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2020/05/10/join-us-for-an-interactive-webinar/</loc><lastmod>2020-05-10T16:01:01-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2019/04/22/great-conversations-at-acrp-in-nashville/</loc><lastmod>2019-04-22T20:44:34-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2019/04/25/2126/</loc><lastmod>2019-04-25T18:06:47-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2019/07/28/want-to-apply-for-nih-funding-but-not-sure-where-to-start/</loc><lastmod>2019-07-28T17:22:39-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2019/09/21/see-you-at-the-rare-disease-research-symposium-2019/</loc><lastmod>2019-09-21T12:33:26-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2019/12/16/start-up-biotech-ind/</loc><lastmod>2019-12-16T13:50:48-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2017/05/18/2248/</loc><lastmod>2019-12-16T15:52:05-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2019/12/16/cro-conference/</loc><lastmod>2019-12-16T18:56:00-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2020/01/12/join-me-for-an-interactive-webinar/</loc><lastmod>2020-01-12T17:15:43-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2020/01/19/westchester-biotech-project-partnership/</loc><lastmod>2020-01-19T19:44:01-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2020/01/19/7-breakthrough-behaviors-at-pmi-nj-meeting/</loc><lastmod>2020-01-19T20:21:16-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2020/10/17/clinical-trial-financial-management-live-virtual-training/</loc><lastmod>2020-10-17T16:06:36-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2020/10/20/now-playing-on-acrptv/</loc><lastmod>2020-10-17T17:01:42-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2020/10/21/2720/</loc><lastmod>2020-10-17T17:32:05-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2021/01/09/2746/</loc><lastmod>2021-01-12T14:16:10-05:00</lastmod></url><url><loc>https://3sixtypharma.com/2025/03/04/happy-new-year-2025/</loc><lastmod>2025-05-26T20:23:32-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2025/05/16/in-the-news/</loc><lastmod>2025-05-26T20:22:38-04:00</lastmod></url><url><loc>https://3sixtypharma.com/2025/05/24/may-we-never-forget/</loc><lastmod>2025-05-26T20:22:08-04:00</lastmod></url></urlset>
